REVANESSE® ULTRA™ with Lidocaine

Key Uses of Revanesse Ultra with Lidocaine

Revanesse Ultra with Lidocaine is commonly used for:

• Deep wrinkles and folds: Effective in treating nasolabial folds and marionette lines.
• Facial volume restoration: Enhances cheek volume and corrects facial asymmetry.
• Jawline and chin contouring: Defines facial structure and improves facial harmony.
• Lip enhancement: Increases lip volume and improves shape.
• Tear trough correction: Reduces under-eye hollows for a refreshed appearance.

Manufacturing Information for Revanesse Ultra with Lidocaine

Revanesse Ultra with Lidocaine is developed and produced by Canadian company Prollenium Medical Technologies from Ontario. Revanesse product line also includes the following products:

• Revanesse Contour: Designed for deep facial sculpting and volume restoration.
• Revanesse Kiss: Specially formulated for lip augmentation and definition.
• Revanesse Pure: A non-cross-linked hyaluronic acid filler for hydration and skin rejuvenation.
• Revanesse Shape+: A robust filler for deeper facial augmentation and contouring.

Expected Benefits and Results of the Treatments

Revanesse Ultra with Lidocaine offers multiple advantages for aesthetic enhancement and facial rejuvenation:

• Minimised discomfort: The inclusion of 0.3% lidocaine reduces pain during injection, improving patient experience.
• Natural-looking volume: The smooth, homogeneous gel integrates seamlessly into the skin for a soft, natural effect.
• High biocompatibility: Made with non-animal stabilised hyaluronic acid (NASHA), reducing the risk of allergic reactions.
• Hydration boost: Hyaluronic acid attracts moisture, improving skin hydration and elasticity over time.
• Versatile application: Effectively treats nasolabial folds, marionette lines, jawline, chin, lips, and under-eye hollows.
• Enhanced skin texture: Improves skin smoothness and structure, reducing fine lines and unevenness.
• Minimal downtime: Patients can return to daily activities shortly after treatment, with quick recovery and minimal swelling.
• Precision and control: The advanced cross-linking technology ensures easy injection and optimal sculpting, giving medical professionals greater control over results.
• Gradual breakdown: Unlike some fillers that degrade unevenly, Revanesse Ultra breaks down naturally and uniformly, preventing lumpiness.
• Improved skin resilience: Stimulates collagen production, helping to maintain skin firmness and structure over time.

Revanesse Ultra with Lidocaine Key Ingredients and Device Features

This filler combines premium ingredients with advanced device properties:

• Hyaluronic acid: 25 mg/ml.
• Lidocaine: 0.3%.
• Phosphate-buffered saline: pH7.

Device features:

• Smooth gel consistency: Allows precise application and even distribution.
• Advanced cross-linking technology: Enhances durability and longevity.
• Ultra-thin needles: Minimises trauma for a comfortable injection experience.

Included Items or Accessories

Each Revanesse Ultra with Lidocaine box comes with the following items:

• Two 1.2 ml prefilled syringes.
• Two 27G sterilised needles.
• Instruction for use.

Administration Method for Revanesse Ultra with Lidocaine

The administration procedure should follow these key steps:

Pre-procedure:

• Assess patient suitability and discuss expected results.
• Cleanse the treatment area thoroughly.
• Apply a topical anaesthetic if needed, despite lidocaine presence.

During procedure:

• Use a 27G needle for precise administration.
• Inject into the deep dermis or subcutaneous layer.
• Apply gentle pressure post-injection to evenly distribute the filler.

Post-procedure:

• Massage treated areas lightly to prevent lump formation.
• Monitor for immediate adverse reactions.
• Provide patient aftercare instructions.

Guidelines for Proper Aftercare

Patients should follow these aftercare steps for optimal results:

• Avoid touching or massaging the treated area for 24 hours.
• Stay hydrated to support hyaluronic acid integration.
• Avoid alcohol, excessive heat, and sun exposure for 48 hours.
• Refrain from intense physical activity for 48 hours.
• Use a cold compress for swelling or bruising.

Duration of Revanesse Ultra with Lidocaine Effects

Revanesse Ultra with Lidocaine lasts between 9-12 months, depending on individual metabolism and lifestyle factors. Patients may require a touch-up session every 6-9 months to maintain optimal results.

Potential Risks and Side Effects

Like all medical treatments, administering Revanesse Ultra with Lidocaine carries potential side effects, including:

Common side effects

• Redness and swelling: Mild inflammation at the injection site, typically subsiding within a few days.
• Bruising: Minor bruising, especially in delicate areas like the lips and under-eye region.
• Tenderness or sensitivity: The treated area may feel slightly sore or sensitive.
• Itching or irritation: Mild itching as the filler settles is possible.
• Lumps or uneven texture: Temporary bumps that often resolve with gentle massage.
• Prolonged swelling or bruising: In some cases, swelling may last longer than a week.
• Asymmetry: Uneven distribution may require correction with additional filler or massage.
• Tingling or numbness: Temporary nerve irritation that usually resolves within days.

Rare side effects

• Allergic reactions: Hypersensitivity to hyaluronic acid or lidocaine can cause swelling, rash, or breathing issues.
• Infection: Bacterial infection at the injection site due to improper technique or aftercare.
• Vascular occlusion: Filler entering a blood vessel can block circulation, leading to skin damage or necrosis. Requires immediate treatment with hyaluronidase.
• Blindness: A rare but severe risk if filler is injected into arteries supplying the eyes. Requires emergency intervention.
• Granuloma formation: Small nodules under the skin that may require medical treatment.
• Persistent pain or discomfort: Unusual pain lasting beyond the normal healing period should be assessed by a medical professional.

Revanesse Ultra with Lidocaine Treatment Contraindications

Before administering Revanesse Ultra with Lidocaine, examine the patients for the presence of the following contraindications since they may cause complications:

• Pregnant or breastfeeding women: Safety data on hyaluronic acid fillers during pregnancy and lactation is insufficient, so treatment is not recommended.
• Individuals with active skin infections: Bacterial, viral (including herpes simplex), or fungal infections in the treatment area increase the risk of complications.
• Patients with severe allergies: Those with a history of anaphylaxis or severe allergic reactions to hyaluronic acid, lidocaine, or other dermal fillers should not receive treatment.
• People with autoimmune disorders: Conditions such as lupus, rheumatoid arthritis, or scleroderma may lead to unpredictable immune responses and delayed healing.
• Patients with bleeding disorders: Individuals with haemophilia or those taking anticoagulants (e.g., warfarin, aspirin, or heparin) have an increased risk of excessive bruising and prolonged bleeding.
• Individuals with a history of keloid or hypertrophic scarring: Patients prone to excessive scar formation may experience complications with filler injections.
• Those with untreated diabetes: Uncontrolled diabetes can affect wound healing and increase the risk of infection.
• Patients with neurological disorders: Those with conditions such as myasthenia gravis or multiple sclerosis should consult a medical professional before considering treatment.
• People with lidocaine sensitivity: Those allergic to lidocaine may experience adverse reactions, including swelling, itching, or systemic effects.
• Patients undergoing immunosuppressive therapy: Those receiving chemotherapy or immunosuppressive drugs may have a weakened immune system, leading to a higher risk of complications.
• Recent facial surgery or invasive aesthetic procedures: Patients should wait at least two weeks after minor treatments (such as laser therapy or chemical peels) and several months after major surgical procedures before getting dermal fillers.
• Underage individuals: Revanesse Ultra with Lidocaine is not approved for use in individuals under 18 years old.
• People with unrealistic expectations: Patients should have a clear understanding of the treatment’s capabilities and limitations to ensure satisfaction with the results.